AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2012
Mar 8, 2012
31982_dirs_2012-03-08_917f68d4-6141-4f09-bc45-bd0527127d9e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2012-03-01
Reporting Person: DRISCOLL FREDERICK W (VP, CFO & Treasurer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-03-01 | Options-right to buy | $1.28 | A | 150000 | Acquired | 2022-03-01 | Common Stock (150000) | Direct |
Footnotes
F1: Options shall vest in four equal annual installments beginning on the first anniversary of the date of grant.